Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
+$656M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$612M |
| 3 |
Biogen
BIIB
|
+$405M |
| 4 |
UnitedHealth
UNH
|
+$353M |
| 5 |
Walmart
WMT
|
+$316M |
Top Sells
| 1 |
Apple
AAPL
|
+$483M |
| 2 |
PepsiCo
PEP
|
+$394M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$248M |
| 4 |
Philip Morris
PM
|
+$246M |
| 5 |
Eli Lilly
LLY
|
+$240M |
Sector Composition
| 1 | Healthcare | 18.91% |
| 2 | Technology | 12.35% |
| 3 | Consumer Discretionary | 10.31% |
| 4 | Financials | 9.99% |
| 5 | Consumer Staples | 8.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
FTAI Aviation
FTAI
$17.8B
| $177K | ﹤0.01% |
13,646
-24,997
| -65% | -$324K |
|
|
SSY
3177
DELISTED
SunLink Health Systems
SSY
| $176K | ﹤0.01% |
155,800
+4,900
| +3% | +$5.54K |
|
|
CFRX
3178
DELISTED
ContraFect Corporation
CFRX
| $176K | ﹤0.01% |
615
+186
| +43% | +$53.2K |
|
3179
Genworth Financial
GNW
$3.52B
| $175K | ﹤0.01% |
39,806
-524,594
| -93% | -$2.31M |
|
|
UFAB
3180
DELISTED
Unique Fabricating, Inc.
UFAB
| $174K | ﹤0.01% |
60,199
+6,300
| +12% | +$18.2K |
|
|
CBMB
3181
DELISTED
CBM Bancorp, Inc.
CBMB
| $174K | ﹤0.01% |
+12,400
| New | +$174K |
|
|
AVGR
3182
DELISTED
Avinger, Inc. Common Stock
AVGR
| $173K | ﹤0.01% |
695
+148
| +27% | +$36.8K |
|
|
NCNA
3183
NuCana
NCNA
$7.56M
| $172K | ﹤0.01% |
+5
| New | +$172K |
|
3184
Akebia Therapeutics
AKBA
$742M
| $170K | ﹤0.01% |
+43,427
| New | +$170K |
|
3185
US Global Investors
GROW
$33M
| $170K | ﹤0.01% |
+85,526
| New | +$170K |
|
|
DESP
3186
DELISTED
Despegar.com
DESP
| $168K | ﹤0.01% |
14,802
-21,898
| -60% | -$249K |
|
3187
Dogness International Corp
DOGZ
$193M
| $168K | ﹤0.01% |
+3,383
| New | +$168K |
|
3188
Dare Bioscience
DARE
$28.2M
| $166K | ﹤0.01% |
17,717
-570
| -3% | -$5.34K |
|
|
PLYA
3189
DELISTED
Playa Hotels & Resorts
PLYA
| $166K | ﹤0.01% |
21,200
-125,700
| -86% | -$984K |
|
3190
Palisade Bio
PALI
$5.38M
| $165K | ﹤0.01% |
22
+20
| +1,000% | +$150K |
|
3191
NextDecade
NEXT
$1.71B
| $164K | ﹤0.01% |
28,400
-1,700
| -6% | -$9.82K |
|
3192
Socket Mobile
SCKT
$8.2M
| $164K | ﹤0.01% |
69,640
+8,421
| +14% | +$19.8K |
|
|
XNET
3193
Xunlei
XNET
$510M
| $164K | ﹤0.01% |
71,700
+14,900
| +26% | +$34.1K |
|
3194
Myomo
MYO
$31.5M
| $163K | ﹤0.01% |
8,813
+2,517
| +40% | +$46.6K |
|
|
JNCE
3195
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $163K | ﹤0.01% |
48,908
+37,308
| +322% | +$124K |
|
3196
Ranger Energy Services
RNGR
$315M
| $161K | ﹤0.01% |
24,986
+10,186
| +69% | +$65.6K |
|
|
LL
3197
DELISTED
LL Flooring Holdings, Inc.
LL
| $160K | ﹤0.01% |
16,200
-551,600
| -97% | -$5.45M |
|
|
ZNB
3198
Zeta Network Group Class A Ordinary Shares
ZNB
$1.73M
| $159K | ﹤0.01% |
+1
| New | +$159K |
|
|
BVSN
3199
DELISTED
Broadvision Inc Com
BVSN
| $159K | ﹤0.01% |
86,000
+400
| +0.5% | +$740 |
|
|
NAGE
3200
Niagen Bioscience, Inc. Common Stock
NAGE
$757M
| $157K | ﹤0.01% |
+39,900
| New | +$157K |
|